ENHANCED MYOCARDIAL PROTECTION DURING ISCHEMIC ARREST - OXYGENATION OF A CRYSTALLOID CARDIOPLEGIC SOLUTION
- 1 January 1983
- journal article
- research article
- Vol. 85 (5) , 769-780
Abstract
To determine if, during elective cardiac arrest, the myocardial protection afforded by a cold (4.degree. C) crystalloid K cardioplegic solution could be improved by oxygenation of the solution, 16 dogs were placed on cardiopulmonary bypass and their hearts were subjected to 4 h of cold cardioplegic arrest. Group 1 hearts (n = 8) received aerated crystalloid solution perfused through the aortic root every 20 min. Group 2 hearts (n = 8) were treated identically except that the crystalloid cardioplegic solution was fully oxygenated. Left ventricular function curves (ejecting heart) were generated before arrest (control) and after 45 min of reperfusion. A cardiac output of 1000 ml/min could be attained in only 2 hearts of group 1 after reperfusion; all but 1 heart of group 2 had excellent functional preservation. Mean postreperfusion ATP levels in group 1 and group 2 hearts were 62 and 89% of control, respectively (P < 0.01). Myocardial water content had increased significantly (P < 0.002) after reperfusion in group 1, but not in group 2. During cardioplegic solution infusion, myocardial O2 consumption (M.ovrhdot.VO2) was 1.42 .+-. 0.15 ml O2/min per 100 g LV for group 1 and 6.91 .+-. 1.27 ml O2/min per 100 g LV for group 2 (P < 0.001). O2 consumed per minute of arrest was 0.027 .+-. 0.003 ml O2/min per 100 g LV for group 1 and 0.128 .+-. 0.015 ml O2/min per 100 g LV for group 2 (P < 0.001). Postreperfusion ultrastructural evaluation of 2 of the group 1 hearts revealed severe ischemic damage in contrast to the normal ultrastructural appearance of 2 of the group 2 hearts. With careful attention given to maintenance of myocardial hypothermia and cardioplegic delivery methods, the myocardial protection afforded by an oxygenated crystalloid cardioplegic solution exceeds that provided by the aerated control and compares favorably with other methods of myocardial protection during ischemic arrest.This publication has 18 references indexed in Scilit:
- Comparison of single-dose and multiple-dose crystalloid and blood potassium cardioplegia during prolonged hypothermic aortic occlusionThe Journal of Thoracic and Cardiovascular Surgery, 1980
- Cold Blood as the Vehicle for Potassium CardioplegiaThe Annals of Thoracic Surgery, 1979
- TIME COURSE OF MYOCARDIAL HIGH-ENERGY PHOSPHATE DEGRADATION DURING POTASSIUM CARDIOPLEGIC ARREST1979
- Effect of cross-clamp time, temperature, and cardioplegic agents on myocardial function after induced arrestThe Journal of Thoracic and Cardiovascular Surgery, 1978
- Myocardial protection by intermittent perfusion with cardioplegic solution versus intermittent coronary perfusion with cold bloodThe Journal of Thoracic and Cardiovascular Surgery, 1978
- The significance of multidose cardioplegia and hypothermia in myocardial preservation during ischemic arrestThe Journal of Thoracic and Cardiovascular Surgery, 1978
- Intraoperative myocardial protection by cardioplegia in hypothermiaThe Journal of Thoracic and Cardiovascular Surgery, 1978
- ADVANTAGES OF BLOOD CARDIOPLEGIA OVER CONTINUOUS CORONARY PERFUSION OR INTERMITTENT ISCHEMIA - EXPERIMENTAL AND CLINICAL-STUDY1978
- STUDIES OF EFFECTS OF HYPOTHERMIA ON REGIONAL MYOCARDIAL BLOOD-FLOW AND METABOLISM DURING CARDIOPULMONARY BYPASS .1. ADEQUATELY PERFUSED BEATING, FIBRILLATING, AND ARRESTED HEART1977
- Influence of vagal stimulation on ventricular contractility, O2 consumption, and coronary flowAmerican Journal of Physiology-Legacy Content, 1967